Association study of Ghrelin Receptor gene polymorphisms in Rheumatoid Arthritis

CER291
2010 Vol.28, N°1
PI 0025, PF 0029
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 20346234 [PubMed]

Received: 18/03/2009
Accepted : 06/10/2009
In Press: 10/03/2010
Published: 15/03/2010

Abstract

OBJECTIVES:
Ghrelin is a newly characterised growth hormone (GH) releasing peptide widely distributed that may play an important role in the regulation of metabolic balance in inflammatory diseases such as rheumatoid arthritis (RA) by decreasing the pro-inflammatory Th1 responses. In this study we investigated the possible contribution of several polymorphisms in the functional Ghrelin receptor to RA susceptibility.
METHODS:
A screening of 3 single nucleotide polymorphisms (SNPs) was performed in a total of 950 RA patients and 990 healthy controls of Spanish Caucasian origin. Genotyping of all 3 SNPs was performed by real-time polymerase chain reaction technology, using the TaqMan 5`-allele discrimination assay.
RESULTS:
We observed no statistically significant deviation between RA patients and controls for the GHSR SNPs analysed. In addition, we performed a haplotype analysis that did not reveal an association with RA susceptibility. The stratification analysis for the presence of shared epitope (SE), rheumatoid factor (RF) or antibodies anti cyclic citrullinated peptide (anti-CCP) did not detect significant association of the GHSR polymorphisms with RA.
CONCLUSIONS:
These findings suggest that the GHSR gene polymorphisms do not appear to play a major role in RA genetic predisposition in our population.